Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127069971 | 12706997 | 1 | I | 201608 | 20160825 | 20160901 | 20160901 | EXP | PHHY2016BR118432 | NOVARTIS | 84.11 | YR | F | Y | 80.00000 | KG | 20160901 | CN | COUNTRY NOT SPECIFIED | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127069971 | 12706997 | 1 | PS | EXELON PATCH | RIVASTIGMINE | 1 | Transdermal | PATCH 10 CM2, QD | 22083 | 9.5 | MG | TRANS-THERAPEUTIC-SYSTEM | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127069971 | 12706997 | 1 | Dementia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127069971 | 12706997 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127069971 | 12706997 | Ankle fracture | |
| 127069971 | 12706997 | Gastrooesophageal reflux disease | |
| 127069971 | 12706997 | Mobility decreased | |
| 127069971 | 12706997 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |